Rajat Bose of rajatkbose.com told CNBC-TV18, "Yesterday Ajanta Pharma tested 200-day exponential moving average for the fifth time since November. It goes down a bit and then bounces back but how many times it would do so before this demand is exhausted around 200-day exponential moving average is that remains to be seen."
"My suggestion is that if it were to go below Rs 1,700 then you bailout of this stock otherwise stay invested because for a long-term investor maybe it pays to remain in that space," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!